Results 131 to 140 of about 206,955 (264)

Development and Validation of an Algorithm to Achieve Complete Registration of Danish Patients with Carcinoma In Situ of the Breast, 2008-2023. [PDF]

Clin Epidemiol
Simonsen MK, Grantzau TL, Jensen MB, Cronin-Fenton D, Offersen BV, Tramm T.   +5 more
europepmc   +1 more source

Posthumously Diagnosed Myhre Syndrome Presenting With Pleural Remodeling and Endometrial Cancer

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Myhre syndrome (OMIM 139210) is a genetic condition defined by neurodevelopmental disability, characteristic facial features, and multisystem proliferative fibrosis. While various types of lung disease have been reported, pleural remodeling leading to restrictive lung disease has not yet been described.
Jeanette Saffir, Karee Morgan, Karigynn Chaimson, Blake E. Funke, Kim L. Sandler, Melissa Hogan, Thomas Cassini   +6 more
wiley   +1 more source

Risk factors for ductal carcinoma in situ: comparisons with invasive breast cancer. [PDF]

Breast Cancer Res
Abe JV, Fukui J, Wilkens LR, Cheng I, Wu AH, Hernandez BY, Loo LWM.   +6 more
europepmc   +1 more source

Complications and Clinical Outcomes Following Modified Endoscopic Denker's With Pyriform Aperture Preservation: A Prospective Analysis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background The modified endoscopic Denker's (MED) approach provides access to all maxillary sinus (MS) walls for resection of various MS and retromaxillary pathologies, but the anteromedial maxilla has historically been resected. This study determined complication rates and outcomes following MED with pyriform aperture (PA) preservation ...
Yasser Almansour, Lane Donaldson, Khaled Kashlan, Swapna Vemuri, Jun Jin, John R. Craig   +5 more
wiley   +1 more source

The Malignant Transformation Rate of Oral Carcinoma In Situ. [PDF]

Laryngoscope
Meci A, Goyal N, Goldenberg D.
europepmc   +1 more source

Under-reporting of carcinoma in situ in patients with high-grade papillary non-muscle-invasive bladder cancer. [PDF]

Bladder Cancer
Cole A, Shoskes DA, Henderson RJ.
europepmc   +1 more source

Design and Application of Nanozymes: Current Trends and Cutting‐Edge Breakthroughs

Advanced Science, EarlyView.
Kelong Fan, Hui Wei, Xiyun Yan
wiley   +1 more source

Trends in Nonsurgical Management for Low-Risk, Hormone Receptor-Positive Ductal Carcinoma In Situ. [PDF]

JAMA Netw Open
Matsui Y, Freeman JQ, Poland S, Howard FM, Chen N, Olopade OI, Huo D.   +6 more
europepmc   +1 more source

Prediction of pathologic upstaging in ductal carcinoma in situ using MRI radiomics combined with clinicopathological features. [PDF]

Breast Cancer Res
Bi C, Li Q, Deng L, Ren Z, Sun D, Ran F, Hu Z, Wang R, Sun S, Yang S, Chen A, Zhao R, Gao D, Wang J, Yang J.   +14 more
europepmc   +1 more source

Breast Events After Treatment of Ductal Carcinoma In Situ in Women: A Population-Based Study. [PDF]

Cancer Med
Chen Q, Campbell I, Elwood M, Cavadino A, Aye PS, Tin Tin S.   +5 more
europepmc   +1 more source